USE OF ENZYME-TREATED CELLS IN IMMUNOTHERAPY OF LEUKÆMIA
- 17 March 1973
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 301 (7803) , 600-601
- https://doi.org/10.1016/s0140-6736(73)90741-1
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Immunotherapy of Cancer: Immunospecific Rejection of Tumors in Recipients of Neuraminidase-Treated Tumor Cells Plus BCGScience, 1971
- Human Lymphocyte Antigen Reactivity Modified by NeuraminidaseScience, 1971
- Active immunotherapy of mouse RC 19 and E ♀ K1 leukaemias applied after the intravenous transplantation of the tumour cellsCellular and Molecular Life Sciences, 1971
- Tumour specific immunogenicity of methylcholanthrene-induced sarcoma cells after incubation in neuraminidase.British Journal of Cancer, 1969
- The role of sialic acid in antigenic expression: further studies of the Landschütz ascites tumourBritish Journal of Cancer, 1968
- AN ALTERATION IN TUMOR HISTOCOMPATIBILITY INDUCED BY NEURAMINIDASETransplantation, 1967